Skip to content

The effect of granisetron and meperidine on shivering after elective cesarean

A Comparison of the prophylactic effect of granisetron and meperidine on reducing shivering after elective cesarean under spinal anesthesia

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170516033992N10
Enrollment
100
Registered
2022-04-12
Start date
2022-05-22
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shivering after elective cesarean section with spinal anesthesia. Delivery by elective caesarean section

Interventions

Intervention 1: Intervention group: The spinal anesthesia will be performed using a standard 25 Quincke needle at L3-4 with hyperbaric 0.5 % bupivacaine 10 mg. Then, after the baby is born, patients w

Sponsors

Oroumia University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Patients undergoing elective cesarean section with spinal anesthesia Age between 20 to 40 years Patients with physical status one and two according to the criteria of the American Anesthesia Association (ASA I, II) Women with full-term pregnancy (more than 37 weeks)

Exclusion criteria

Exclusion criteria: Chronic diseases Hypertension Diabetes Psychological disorders Drug allergy Cesarean section more than an hour

Design outcomes

Primary

MeasureTime frame
Shivering. Timepoint: Every 5 minutes after surgery. Method of measurement: Clinical examination.

Secondary

MeasureTime frame
Mean arterial pressure (MAP). Timepoint: Before, during and every 5 minutes after surgery. Method of measurement: Monitoring.;Heart rate. Timepoint: Before, during and every 5 minutes after surgery. Method of measurement: Monitoring.;Percentage of arterial blood oxygen saturation. Timepoint: Before, during and every 5 minutes after surgery. Method of measurement: Monitoring.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Tohid Karami

Oroumia University of Medical Sciences

karami.t@umsu.ac.ir+98 44 3346 5079

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026